About International Journal of Biomedical and Advance Research

International Journal of Biomedical and Advance Research

The International Journal of Biomedical and Advance Research, commonly shortened to IJBAR, is an Indian biomedical journal identified by online ISSN 2229-3809 and print ISSN 2455-0558. The Journals World record for this title carries those two ISSNs together, and the same pairing appears on the journal's published articles, which also carry the journal DOI prefix 10.7439/ijbar and the CODEN IJBABN. That combination of identifiers is the safest way to distinguish this title from the many similarly named biomedical journals now published in India and elsewhere, several of which use near-identical phrases such as biomedical research, advanced research or biomedical and advance research in a different word order.

As its title signals, the journal positions itself at the broad end of biomedical publishing rather than within a single specialty. The Journals World record summarises its early thematic centre as medicinal plant research, diabetes, cardiovascular risk and lipoproteins, anaesthesia and pain management, anaesthesia and sedative agents, innovations in medical education, bone fractures and treatment, clinical laboratory practice and quality control, and maternal and fetal healthcare. Published examples that can be checked in indexing services confirm that breadth in practice: readers will find clinical studies from Indian teaching hospitals, laboratory and pharmacology work, periodontology and oral health research, orthopaedic outcome studies, public health writing on migrants and refugees, and case reports on uncommon presentations such as tuberculosis of the wrist. This is, in other words, a general biomedical venue whose value lies in accessibility for hospital-based and university-based researchers across specialties, not in a narrow subspecialty identity.

That breadth also creates the central task for any author or reader using this journal: fit must be judged article by article. A broad journal can be a legitimate home for a sound local clinical audit, a small pharmacology experiment or a carefully documented case, provided the methods are transparent and the claims match the data. It is not a substitute for a high-selectivity specialty journal, and its metrics should be read in that context. The Journals World record lists an h-index of 24 for this title in its underlying bibliometric snapshot. Such a figure describes cumulative citation activity in the database from which it was drawn; it is not a Journal Impact Factor, it is not issued by the publisher, and it should not be compared directly with metrics drawn from a different database or a different year.

Journal at a Glance

• Full title: International Journal of Biomedical and Advance Research (IJBAR)
• Online ISSN: 2229-3809
• Print ISSN: 2455-0558
• Journal DOI prefix: 10.7439/ijbar, as printed on published articles
• CODEN: IJBABN, as printed on published articles
• Country: India, as listed in the Journals World record
• Field: General biomedicine and clinical medicine
• Article examples verified: Clinical, pharmacological, dental, orthopaedic, laboratory and public-health articles bearing the ISSNs and DOI prefix above

History and Development

Recovering a precise founding narrative for IJBAR from primary publisher material is harder than for a society journal, and this profile does not invent one. What can be verified from the published record itself is the journal's presence in the early to mid-2010s with a regular volume and issue sequence: articles from 2015, 2016 and 2018, for example, appear with volume numbers 6, 7 and 9 respectively, page numbering within issues, structured abstracts, author affiliations concentrated in Indian medical and pharmacy institutions, and a consistent article header carrying the ISSNs, DOI prefix and CODEN. That pattern is consistent with a journal that began publishing several years before 2015 and settled into a frequent-issue rhythm during that period. Any exact launch year, founding editor or publisher history that is not stated on a current official page should be treated as could not be verified for the purposes of this profile, rather than repeated from an unverified aggregator.

The journal's published geography is also informative. Corresponding authors in the verifiable sample are based in institutions such as medical colleges, pharmacy institutes and research hospitals in Maharashtra, Telangana, Karnataka and Chhattisgarh, among other Indian states. That distribution matches the Journals World country listing of India and helps explain the journal's subject mix: a strong presence of hospital-based clinical observation, pharmaceutical formulation work from pharmacy colleges, and community and public-health topics of direct relevance to Indian practice. At the same time, a general biomedical title inevitably competes for attention with much larger international general medical journals. IJBAR's realistic niche, on the evidence of its own articles, is therefore regional and practical: studies whose primary audience is clinicians and researchers working in comparable settings, and work that might struggle for space in a highly selective international title yet still deserves a citable, DOI-bearing record.

Readers should also be alert to title collision. Several distinct journals use very similar names in this space, including titles centred on advanced biotechnology, biomedical research and health sciences, and biomedicine in a shorter form. Those are separate publications with different ISSNs and publishers. Citing IJBAR correctly means citing the ISSN pair 2229-3809 and 2455-0558 and, for individual articles, the 10.7439 DOI. If a reference list, a curriculum vitae entry or a library record gives a different ISSN for a supposedly IJBAR article, the discrepancy should be resolved against the article PDF header before the citation is trusted.

Scope and Subject Areas

The scope below follows the thematic centre recorded for this journal and the subjects demonstrated by its verifiable published articles. It is a guide to fit, not a promise that every topic in a category will be accepted. In a broad journal, editors typically weigh completeness of methods, ethical documentation and clarity of reporting at least as heavily as novelty.

Medicinal Plant Research and Pharmacology

Work on plant-derived compounds, traditional preparations and pharmacological evaluation forms one of the recorded strands of this journal. A credible submission in this area identifies the plant material precisely, describes extraction and preparation in reproducible detail, states the model or assay used, and avoids therapeutic claims that go beyond the experiment actually performed. Formulation work, such as mucoadhesive tablet development and in vivo evaluation reported in the journal's pages, belongs in the same conversation: the contribution is usually practical and incremental, showing how a preparation behaves under stated conditions, rather than a claim of clinical efficacy in patients. Authors should separate clearly what was shown in vitro, what was shown in an animal model, and what remains untested in humans.

Diabetes, Cardiovascular Risk and Lipoproteins

Metabolic and cardiovascular topics are explicitly recorded for this journal, and they suit its hospital-based authorship well. Useful contributions include lipid profile studies in defined patient groups, observational work on risk factors in a stated population, and carefully bounded comparisons that acknowledge confounding. The standard to aim for is specificity: define the population, the recruitment setting, the laboratory methods and the statistical approach, and present results with the uncertainty that a modest sample size implies. A single-centre lipid study from north-eastern India, of the kind the journal has published, can inform local practice and generate hypotheses; it cannot by itself settle a national treatment question, and a well-written discussion will say so plainly.

Anaesthesia, Pain and Perioperative Care

Anaesthesia and pain management, including sedative agents, is another recorded strand. This is a field where small, well-run comparative studies and observational audits can change day-to-day practice in a department, even when they would not change international guidelines. Submissions should document ethics approval, consent, randomisation or allocation where applicable, blinding where feasible, and adverse events with the same care as primary outcomes. Case material involving unusual reactions or difficult airways can also be valuable when it teaches a transferable lesson, documents imaging or monitoring clearly, and protects patient identity rigorously.

Clinical Medicine, Orthopaedics and Case Reports

The journal's pages include orthopaedic outcome work, such as subjective outcome measures after fixation of forearm fractures, alongside general clinical articles and case reports. Case reports earn their place when the case is genuinely uncommon, when the diagnostic reasoning is instructive, or when imaging and follow-up are unusually complete. A report of wrist tuberculosis with rice body formation, for example, teaches because the presentation mimics a tumour mass and the diagnosis is easy to delay. Authors of case reports should follow recognised reporting care, obtain and state consent for publication, and include follow-up long enough for the outcome claim to be meaningful.

Dental, Periodontal and Oral Health Research

Periodontology and oral health research appears in the verifiable record, including a year-long comparative follow-up on chlorine dioxide based toothpaste and mouthrinse in periodontitis patients. Dental submissions fit the journal when they connect oral findings to systemic health, use validated clinical indices, report examiner calibration, and follow patients long enough for plaque and gingival measures to be interpretable. Short, uncontrolled observations with exaggerated product claims are the weakest form of this genre and should be avoided. Where a commercial product is studied, funding and any relationship with a manufacturer must be disclosed explicitly.

Medical Education and Health Systems

Innovations in medical education are part of the recorded scope, and the journal has carried work on video assisted learning for slow learners, with authors from Indian medical institutes. Education research is welcome in general biomedical journals when it is designed as research rather than presented as anecdote: a defined learner group, a described intervention, a comparator or a reasoned justification for its absence, and outcome measures that go beyond satisfaction alone. Health systems and public-health writing, including work on the health concerns of migrants and refugees, fits the same standard: frame the population, cite the policy context accurately, and distinguish evidence from advocacy while still allowing a clear recommendation.

Clinical Laboratory Practice and Quality Control

Laboratory practice and quality control form a quiet but important part of the recorded scope. Studies of analytes such as uromodulin in chronic kidney disease, measured by ELISA across disease stages and correlated with estimated glomerular filtration rate and creatinine, illustrate the genre: the value lies in assay detail, reference handling, and honest correlation reporting. Laboratory submissions should state sample handling, assay manufacturer and method where relevant, quality control procedures, and the statistical treatment of skewed distributions. Maternal and fetal healthcare, also recorded for this journal, overlaps here through screening and diagnostic studies, where sensitivity claims must always be tied to the population and prevalence studied.

Maternal, Fetal and Community Health

Maternal and fetal healthcare completes the recorded thematic centre. Obstetric audits, antenatal screening evaluations and maternal outcome studies from teaching hospitals are natural submissions, provided denominators are clear and referral bias is discussed, since a tertiary hospital sample rarely represents a whole community. Community health extensions, including reproductive health and nutrition observations, should define sampling honestly and avoid generalising from a convenience sample to a state or nation. In all of these areas, ethics documentation for research involving pregnant participants and children deserves particular care and should be stated in the manuscript, not left for a reviewer to request.

Article Types and How to Judge Fit

On the evidence of its published issues, IJBAR publishes original research articles, review articles and case reports, with article headers labelling those types explicitly. That mix is typical of a general biomedical journal serving hospital and pharmacy college authors. Before submitting, an author should read several recent articles of the same type in the journal, match their structure, structured abstract, keyword style, referencing and length, and check that the journal's current submission route is the one stated on its own site at the time of submission. Publisher web addresses for journals of this size change over time, and third-party submission portals that imitate a journal are a known hazard in this segment of publishing, so the route should always be reached from a trusted listing or the article PDFs themselves, not from an unsolicited email invitation.

Fit should also be judged by audience. If the primary contribution is a local prevalence figure, a departmental audit, a formulation optimisation or a teaching case, a broad journal read by comparable practitioners can be a proportionate home. If the claim is a practice-changing therapeutic effect, the evidentiary bar in any journal is controlled design, adequate power and prospective registration where applicable, and authors should ask honestly whether their study meets it. Submitting a small observational study with guideline-changing language damages credibility in any venue and is the most common reason broad-journal articles are criticised after publication.

Peer Review, Ethics and Reporting Standards

Specific peer review timelines, fees and editorial board details for this journal are not publicly disclosed in the sources verified for this profile, and no figure is invented here. Authors should therefore ask those questions directly before submission: whether a fee is charged and at what stage, what the review model is, what the expected timeline is, and who the responsible editor is. A legitimate journal will answer those questions on its own pages or by reply from an editorial address that matches its site. Requests for payment to a personal account, promises of guaranteed acceptance, or acceptance within a few days for a full research article are warning signs in any journal, not a feature to be welcomed.

Whatever the venue, biomedical manuscripts must carry the standard ethical apparatus: institutional ethics approval with a committee name and, where the journal requests it, an approval number; informed consent or a stated waiver; trial registration for prospective interventional studies; funding and conflict of interest statements; and authorship that follows contributorship rather than hierarchy. Reporting should follow the recognised guideline for the study type, such as CONSORT for trials, STROBE for observational studies and CARE for case reports. Data should be presented so that another group could repeat the analysis, and limitations should be written by the authors rather than discovered by the readers.

Indexing, Metrics and How to Read Them

The Journals World record for this title lists an h-index of 24. That figure should be understood as a database snapshot: it counts, within one bibliometric source, the number of articles that have reached at least that many citations. It will differ from figures in other databases and will change over time. No Journal Impact Factor from Clarivate, CiteScore from Scopus or SCImago quartile is asserted in this profile, because none was verified from an official listing for this title during preparation. If a website attributes a high impact factor to IJBAR, the claim should be checked in the issuing organisation's own list for the relevant year before it is used in an application or promotion file, since unofficial impact factor claims are widespread for journals with similar names.

For most authors considering this journal, indexing questions matter more than a single metric: is the article assigned a DOI, will it be discoverable in the scholarly search services the author's institution uses, and will the author's university recognise the venue for the purpose intended? Those questions have verifiable answers. Check the DOI resolves, check the ISSN in an authoritative serials listing, and check the institution's own approved list where one exists. That three-part check protects an author far better than any headline metric, and it takes only a few minutes.

Audience and Practical Use

The natural readership for IJBAR, on the evidence of its content, is clinicians, pharmacists, dentists, laboratory specialists and medical educators working in Indian and comparable South Asian settings, together with postgraduate trainees learning to design and report studies. Postgraduate dissertations are a major source of hospital-based research in India, and a general journal that publishes sound dissertation-derived work performs a real service, provided supervision ensures the reporting is complete. Readers using the journal for clinical decisions should appraise each article on its own methods, as they would in any broad journal, and should look for corroboration in guidelines and larger studies before changing practice on the basis of a single small study.

Librarians and research managers should catalogue this title by its ISSN pair and DOI prefix, and should be careful in discovery layers where similar titles cluster together. A misfiled article under a near-identical journal name creates citation errors that persist for years. The CODEN IJBABN printed on the articles provides an additional check in older indexing workflows.

Frequently Asked Questions

Is the International Journal of Biomedical and Advance Research the same as other biomedical journals with similar names?

No. Several distinct journals use similar wording. This profile covers only the title with online ISSN 2229-3809, print ISSN 2455-0558, DOI prefix 10.7439/ijbar and CODEN IJBABN. Always match at least the ISSN before assuming two records describe the same journal.

What subjects does IJBAR cover?

Its recorded centre includes medicinal plant research, diabetes and cardiovascular risk, anaesthesia and pain, medical education, fractures and orthopaedic outcomes, laboratory practice, and maternal and fetal health, with published examples also in dentistry, pharmacology and public health. It is a general biomedical journal rather than a single-specialty title.

Does this profile confirm an impact factor for IJBAR?

No. No Clarivate Journal Impact Factor or Scopus CiteScore for this title was verified from an official listing during preparation, so none is stated. The h-index of 24 in the Journals World record is a separate bibliometric snapshot and should not be presented as an impact factor.

What should authors check before submitting?

Check the current official submission route, any fee and the stage at which it is charged, the review timeline, and whether the author's institution recognises the journal for the intended purpose. Confirm ethics approval, consent and reporting guideline compliance in the manuscript itself.

Conclusion

This profile identifies International Journal of Biomedical and Advance Research by the identifiers and publisher information verified from the sources listed by the author of this profile. Readers should confirm time-sensitive details such as fees, editorial board membership, indexing status and submission requirements on the journal's own current pages before submitting a manuscript or citing a metric, because those details change over time and secondary listings can lag behind the publisher's own record.